Working to develop topical solutions (eye drops) that will intercept presbyopia and cataracts and improve visual acuity, the Presbyopia/Cataracts Venture team is developing collaborations to protect the vision of individuals in the future.

Presbyopia is considered a visual condition of everyone over the age of 40 and census figures estimate that 112 million people in the United States (U.S.) had the condition in 2006.² The formation of cataracts remains the leading cause of blindness worldwide, affecting 20 million people. Though treatable through surgery, access barriers exist in many countries, preventing individuals from getting surgery.³ More than 3.2 million surgical procedures are performed each year to address the condition in the U.S. alone.⁴ Cataract surgery, while known to be highly successful, comes with risks and may require follow-up surgery.